FTC sues Endo over ‘pay-for-delay’ settlements


FTC sues Endo over ‘pay-for-delay’ settlements

Mark Van Scyoc / Shutterstock.com

The Federal Trade Commission (FTC) has sued Endo Pharmaceuticals for allegedly violating competition laws by agreeing to so-called pay-for-delay settlements surrounding the launch of generic versions of two drugs.

FTC, generics, Watson Laboratories, Endo Pharmaceuticals, Opana ER, Lidoderm, Teikoku Seiyaku, Teikoku Pharma USA, pay for delay, Federal Trade Commission